Gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes

Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2008. === This electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections. === Vita. === Includes bibliographical references (p. 289-300). === Me...

Full description

Bibliographic Details
Main Author: Alemán, José O. (José Orlando)
Other Authors: Gregory Stephanopoulos.
Format: Others
Language:English
Published: Massachusetts Institute of Technology 2008
Subjects:
Online Access:http://hdl.handle.net/1721.1/43743
id ndltd-MIT-oai-dspace.mit.edu-1721.1-43743
record_format oai_dc
spelling ndltd-MIT-oai-dspace.mit.edu-1721.1-437432019-05-02T15:52:56Z Gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes Development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes Alemán, José O. (José Orlando) Gregory Stephanopoulos. Harvard University--MIT Division of Health Sciences and Technology. Harvard University--MIT Division of Health Sciences and Technology. Harvard University--MIT Division of Health Sciences and Technology. Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2008. This electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections. Vita. Includes bibliographical references (p. 289-300). Metabolic diseases are an increasing health concern in the developed world. Type 2 Diabetes, (T2D) affects over 100 million people worldwide and significantly contributes to chronic diseases such as atherosclerosis and kidney failure. This condition is characterized by deregulation of glucose homeostasis through the development of insulin resistance, manifested as increased glucose production in the liver. Hepatic gluconeogenesis provides de novo formation of glucose from three carbon precursors such as glycerol, lactate, pyruvate and alanine. The upregulation of this pathway underlies the persistent hyperglycemia observed in diabetic patients. We have developed stable isotope tracer methods to reconstruct hepatic glucose production fluxes by infusion of [13C, 2H]-glycerol and mass spectrometry analysis of plasma metabolites. Using this methodology we observe physiologic changes in liver cell lines and primary hepatocyte cultures in the presence of hormones insulin/glucagon and in response to gluconeogenic precursor availability. We put forth the hypothesis that in the presence of glycerol as a gluconeogenic substrate, glucose-6-phosphatase has an important role in modulating metabolic flux through upper gluconeogenesis. Infusion of simultaneous tracer combinations in vivo including a novel [U-13C,2H5]-glycerol allow detailed net flux and reversibility reconstruction of upper gluconeogenesis to an unprecedented degree in a single experiment. We deployed the developed methods to probe glucose overproduction in the liver insulin receptor knockout (LIRKO) transgenic model of Type 2 Diabetes, and found unexpected similarities in the metabolic flux profile not observed by genomic, protein or metabolite measurements. (cont.) Our results underscore the importance of flux measurement as a physiologic parameter akin to gene and protein expression in revealing the metabolic phenotype of cells, tissues and organisms. These methods have the potential to contribute as clinical assays to characterize excess glucose production as well as in drug development for new targets to control hepatic glucose production. by José O. Alemán. Ph.D. 2008-12-11T16:56:48Z 2008-12-11T16:56:48Z 2008 2008 Thesis http://hdl.handle.net/1721.1/43743 263175720 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 333 p. application/pdf Massachusetts Institute of Technology
collection NDLTD
language English
format Others
sources NDLTD
topic Harvard University--MIT Division of Health Sciences and Technology.
spellingShingle Harvard University--MIT Division of Health Sciences and Technology.
Alemán, José O. (José Orlando)
Gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes
description Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2008. === This electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections. === Vita. === Includes bibliographical references (p. 289-300). === Metabolic diseases are an increasing health concern in the developed world. Type 2 Diabetes, (T2D) affects over 100 million people worldwide and significantly contributes to chronic diseases such as atherosclerosis and kidney failure. This condition is characterized by deregulation of glucose homeostasis through the development of insulin resistance, manifested as increased glucose production in the liver. Hepatic gluconeogenesis provides de novo formation of glucose from three carbon precursors such as glycerol, lactate, pyruvate and alanine. The upregulation of this pathway underlies the persistent hyperglycemia observed in diabetic patients. We have developed stable isotope tracer methods to reconstruct hepatic glucose production fluxes by infusion of [13C, 2H]-glycerol and mass spectrometry analysis of plasma metabolites. Using this methodology we observe physiologic changes in liver cell lines and primary hepatocyte cultures in the presence of hormones insulin/glucagon and in response to gluconeogenic precursor availability. We put forth the hypothesis that in the presence of glycerol as a gluconeogenic substrate, glucose-6-phosphatase has an important role in modulating metabolic flux through upper gluconeogenesis. Infusion of simultaneous tracer combinations in vivo including a novel [U-13C,2H5]-glycerol allow detailed net flux and reversibility reconstruction of upper gluconeogenesis to an unprecedented degree in a single experiment. We deployed the developed methods to probe glucose overproduction in the liver insulin receptor knockout (LIRKO) transgenic model of Type 2 Diabetes, and found unexpected similarities in the metabolic flux profile not observed by genomic, protein or metabolite measurements. === (cont.) Our results underscore the importance of flux measurement as a physiologic parameter akin to gene and protein expression in revealing the metabolic phenotype of cells, tissues and organisms. These methods have the potential to contribute as clinical assays to characterize excess glucose production as well as in drug development for new targets to control hepatic glucose production. === by José O. Alemán. === Ph.D.
author2 Gregory Stephanopoulos.
author_facet Gregory Stephanopoulos.
Alemán, José O. (José Orlando)
author Alemán, José O. (José Orlando)
author_sort Alemán, José O. (José Orlando)
title Gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes
title_short Gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes
title_full Gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes
title_fullStr Gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes
title_full_unstemmed Gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in Type 2 Diabetes
title_sort gluconeogenesis as a system : development of in vivo flux analysis of hepatic glucose production in type 2 diabetes
publisher Massachusetts Institute of Technology
publishDate 2008
url http://hdl.handle.net/1721.1/43743
work_keys_str_mv AT alemanjoseojoseorlando gluconeogenesisasasystemdevelopmentofinvivofluxanalysisofhepaticglucoseproductionintype2diabetes
AT alemanjoseojoseorlando developmentofinvivofluxanalysisofhepaticglucoseproductionintype2diabetes
_version_ 1719030101333508096